ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional

A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis

ClinicalTrials.gov ID: NCT06159725

Public ClinicalTrials.gov record NCT06159725. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 6:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1b/2a Study To Evaluate The Safety Of CMTX-101 In Combination With Inhaled Antibiotics In People With Cystic Fibrosis Chronically Infected With Pseudomonas Aeruginosa

Study identification

NCT ID
NCT06159725
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Clarametyx Biosciences, Inc.
Industry
Enrollment
43 participants

Conditions and interventions

Interventions

  • CMTX-101 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 23, 2024
Primary completion
Nov 13, 2025
Completion
Nov 13, 2025
Last update posted
May 4, 2026

2024 – 2025

United States locations

U.S. sites
23
U.S. states
18
U.S. cities
23
Facility City State ZIP Site status
University of Alabama, Birmingham Birmingham Alabama 35294
Stanford University Palo Alto California 94304
University of California, San Francisco San Franciso California 94143
National Jewish Health Denver Colorado 80206
Central Florida Pulmonary Group, PA Orlando Florida 32803
St Luke's Sleep Medicine and Research Center Boise Idaho 83702
Cystic Fibrosis Institute Northfield Illinois 60093
University of Kansas Kansas City Kansas 66160
Johns Hopkins University Baltimore Maryland 21287
Boston Children's Hospital Boston Massachusetts 02115
University of Michigan Ann Arbor Michigan 48109
New York Medical College Hawthorne New York 10532
Lenox Hill Hospital New York New York 10075
Rainbow Babies and Children's Hospital/University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Nationwide Children's Hospital Columbus Ohio 43205
PennState Health Hershey Pennsylvania 17003
University of Pennsylvania Philadelphia Pennsylvania 19104
UPMC Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15224
Medical University of South Carolina Charleston South Carolina 29425
Vanderbilt University Nashville Tennessee 37235
University of Utah Salt Lake City Utah 84132
Virginia Commonwealth University Richmond Virginia 23219
Seattle Children's Hospital Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06159725, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06159725 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →